Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)

Bos, R.; Nieuwenhuizen, W.

Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)

article

1992

Bos, R.

Nieuwenhuizen, W.

Topics

fibrin monoclonal antibody plasminogen activator tissue plasminogen activator urokinase drug carrier cell fusion conference paper drug binding drug efficacy drug megadose endothelium cell enzyme activity fibrinolysis fibrinolytic therapy hybridoma plasminogen activation antibody specificity drug effect immunology metabolism Antibodies, Monoclonal Antibody Specificity Drug Carriers Fibrin Fibrinolysis Human Kinetics Plasminogen Activator Inhibitor 1 Tissue Plasminogen Activator Urinary Plasminogen Activator

TNO Identifier

232010

Repository link

https://resolver.tno.nl/uuid:77b4c0b3-9b2b-4aaf-8924-606909261a52

DOI

https://dx.doi.org/10.1111/j.1749-6632.1992.tb51644.x

ISSN

00778923

Source

Annals of the New York Academy of Sciences, 667, pp. 428-430.

Pages

428-430

Files

To receive the publication files, please send an e-mail request to TNO Repository.

Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)

Make TNO yours!